Baudax Bio, Inc. (BXRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jun 25, 2025, 8:00 PM EDT

Baudax Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2017
Period Ending
Jun '25 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2017
02192665-
Upgrade
Market Cap Growth
-30.95%-90.48%-30.04%-59.05%--
Upgrade
Enterprise Value
-531266-
Upgrade
Last Close Price
0.003.18306.881414.009688.01-
Upgrade
PS Ratio
0.001.3917.1753.75--
Upgrade
PB Ratio
0.00-0.071.40-1.79-3.87-
Upgrade
EV/Sales Ratio
-3.812.7123.35--
Upgrade
Debt / Equity Ratio
-6.76-0.330.65-0.62-0.05-
Upgrade
Asset Turnover
0.070.040.020.01--
Upgrade
Inventory Turnover
-2.800.61---
Upgrade
Quick Ratio
0.020.261.051.682.30-
Upgrade
Current Ratio
0.070.301.502.032.610.11
Upgrade
Return on Assets (ROA)
-114.93%-70.57%-53.66%-56.74%-55.85%-119.93%
Upgrade
Return on Capital (ROIC)
--819.79%-406.39%---
Upgrade
Earnings Yield
-14632692.31%-3332.06%-106.63%-287.17%-50.31%-
Upgrade
FCF Yield
-27590384.62%-1576.23%-266.85%-168.67%-79.38%-
Upgrade
Buyback Yield / Dilution
-2403.74%-505.82%-311.07%---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.